Expand Energy vs Ovintiv
EXE and OVV side by side, both in crude petroleum and natural gas. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXE and OVV compare
Expand Energy and Ovintiv are about the same size, with market caps of $20.4B and $18.0B.
On earnings, Expand Energy is cheaper: it trades at 7.7× trailing earnings, against 18.5× for Ovintiv.
Expand Energy grew revenue faster over the last twelve months (28.2% versus 6.0% for Ovintiv).
Expand Energy keeps more of each dollar of sales as profit, with a net margin of 19.8% compared with 9.4% at Ovintiv.
Both pay dividends: Expand Energy yields 2.6% and Ovintiv 1.8%.
Expand Energy scores higher on the StockData Score (16 against 11 for Ovintiv), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXE | OVV |
|---|---|---|
| Size and price | ||
| Market cap | $20.4B | $18.0B |
| Share price | $88.53 | $65.39 |
| Change, 1 year | −25.9% | 71.0% |
| Change, 5 years | 43.4% | 89.5% |
| Beta (5Y) | 0.60 | 0.84 |
| Employees | 1,600 | 1,465 |
| StockData Score | ||
| Total score | 16 (better) | 11 |
| Valuation score | 5 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 4 (better) | 2 |
| Health score | 3 | 4 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 7.7× (better) | 18.5× |
| P/S | 1.5× (better) | 1.8× |
| P/B | 1.0× (better) | 1.6× |
| EV/EBITDA | 3.8× (better) | 6.8× |
| P/FCF | 7.9× (better) | 8.0× |
| FCF yield | 12.7% (better) | 12.6% |
| Fair value | $101.66 | $43.48 |
| Margin of safety | 12.9% (better) | −50.4% |
| Growth | ||
| Revenue growth (TTM) | 28.2% (better) | 6.0% |
| Revenue growth, 5Y average | 18.3% (better) | 7.9% |
| Net income growth (TTM) | 218% (better) | 54.6% |
| EPS growth (TTM) | 228% (better) | 56.2% |
| Profitability | ||
| Operating margin | 25.7% (better) | 9.7% |
| Net margin | 19.8% (better) | 9.4% |
| FCF margin | 18.6% | 23.2% (better) |
| Return on equity | 14.6% (better) | 8.4% |
| Return on invested capital | 12.2% (better) | 6.3% |
| Financial health | ||
| Debt / equity | 0.24 (better) | 0.32 |
| Net debt / EBITDA | 0.69 (better) | 0.96 |
| Interest coverage | 17.4× (better) | 2.4× |
| Current ratio | 0.90 | 1.01 (better) |
| Altman Z-score | 2.32 (better) | 2.21 |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 1.8% |
| Payout ratio | 19.9% | 35.0% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 26.2% |
| Buyback yield | 4.4% (better) | 3.3% |
| Shareholder yield | 7.0% (better) | 5.1% |
| Ownership | ||
| Held by institutions | 95.5% | 93.1% |
| Held by insiders | 0.33% | 0.48% |
| Insider net buying, 12 months | $877K (better) | −$5.7M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.1% | 4.1% |
Go deeper
- EXE stock overview
- EXE income statement
- EXE valuation and score
- OVV stock overview
- OVV income statement
- OVV valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.